| pubmed-article:3087772 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3087772 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:3087772 | lifeskim:mentions | umls-concept:C0699040 | lld:lifeskim |
| pubmed-article:3087772 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
| pubmed-article:3087772 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:3087772 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:3087772 | lifeskim:mentions | umls-concept:C1314939 | lld:lifeskim |
| pubmed-article:3087772 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:3087772 | pubmed:dateCreated | 1986-7-30 | lld:pubmed |
| pubmed-article:3087772 | pubmed:abstractText | NMR spectroscopy is one of the few techniques which has the sensitivity to detect subtle changes to the surface chemistry of cells. It has previously been demonstrated that high resolution 1H NMR methods can distinguish tumour cells with the capacity to metastasis and this information appears to arise from a type of proteolipid in or attached to the plasma membrane. Here we report that the 1H NMR signal, which we have used to identify metastatic cells in rat tumours, is significantly reduced in intensity after cultured cells are treated with trypsin/EDTA. The long T2 relaxation value (greater than 350 ms) observed in metastatic cells is absent after enzyme treatment. 2D scalar correlated NMR (COSY) spectra of these treated cells show that a cross peak normally associated with malignancy and metastatic disease is markedly reduced. These findings indicate that the plasma membrane lipid particle which generates the high resolution spectrum is directly affected by trypsin/EDTA. Alterations to the cell surface properties were also demonstrated in vivo since reduced numbers of metastases were observed in animals injected with enzyme-treated cells. The correlation between the absence of a long T2 relaxation value and the diminished numbers of metastases in animals suggests that the plasma membrane particle is involved in the metastatic PROCESS. | lld:pubmed |
| pubmed-article:3087772 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3087772 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3087772 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3087772 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3087772 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3087772 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3087772 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3087772 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:3087772 | pubmed:issn | 0014-5793 | lld:pubmed |
| pubmed-article:3087772 | pubmed:author | pubmed-author:GregoryPP | lld:pubmed |
| pubmed-article:3087772 | pubmed:author | pubmed-author:FrewR MRM | lld:pubmed |
| pubmed-article:3087772 | pubmed:author | pubmed-author:WilliamsP GPG | lld:pubmed |
| pubmed-article:3087772 | pubmed:author | pubmed-author:WrightL CLC | lld:pubmed |
| pubmed-article:3087772 | pubmed:author | pubmed-author:HolmesK TKT | lld:pubmed |
| pubmed-article:3087772 | pubmed:author | pubmed-author:MountfordC... | lld:pubmed |
| pubmed-article:3087772 | pubmed:author | pubmed-author:MayG LGL | lld:pubmed |
| pubmed-article:3087772 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3087772 | pubmed:day | 23 | lld:pubmed |
| pubmed-article:3087772 | pubmed:volume | 202 | lld:pubmed |
| pubmed-article:3087772 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3087772 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3087772 | pubmed:pagination | 122-6 | lld:pubmed |
| pubmed-article:3087772 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:3087772 | pubmed:meshHeading | pubmed-meshheading:3087772-... | lld:pubmed |
| pubmed-article:3087772 | pubmed:meshHeading | pubmed-meshheading:3087772-... | lld:pubmed |
| pubmed-article:3087772 | pubmed:meshHeading | pubmed-meshheading:3087772-... | lld:pubmed |
| pubmed-article:3087772 | pubmed:meshHeading | pubmed-meshheading:3087772-... | lld:pubmed |
| pubmed-article:3087772 | pubmed:meshHeading | pubmed-meshheading:3087772-... | lld:pubmed |
| pubmed-article:3087772 | pubmed:meshHeading | pubmed-meshheading:3087772-... | lld:pubmed |
| pubmed-article:3087772 | pubmed:meshHeading | pubmed-meshheading:3087772-... | lld:pubmed |
| pubmed-article:3087772 | pubmed:meshHeading | pubmed-meshheading:3087772-... | lld:pubmed |
| pubmed-article:3087772 | pubmed:meshHeading | pubmed-meshheading:3087772-... | lld:pubmed |
| pubmed-article:3087772 | pubmed:meshHeading | pubmed-meshheading:3087772-... | lld:pubmed |
| pubmed-article:3087772 | pubmed:meshHeading | pubmed-meshheading:3087772-... | lld:pubmed |
| pubmed-article:3087772 | pubmed:meshHeading | pubmed-meshheading:3087772-... | lld:pubmed |
| pubmed-article:3087772 | pubmed:year | 1986 | lld:pubmed |
| pubmed-article:3087772 | pubmed:articleTitle | Cell surface involvement in cancer metastasis: an NMR study. | lld:pubmed |
| pubmed-article:3087772 | pubmed:publicationType | Journal Article | lld:pubmed |
